GLP-1 drugs alone aren’t a magic fix — My patient’s story shows what really works
Post Content
WHO issues guidelines on GLP-1 therapies for obesity treatment: Understanding the impact, safety considerations, and who can benefit
This week, the World Health Organization entered a new arena with its first global guideline on GLP-1 therapies for obesity treatment. Released on December 1, 2025, the document conditionally recommends drugs like semaglutide, liraglutide, and tirzepatide for adults with a BMI of 30 or higher-but only as part of a lifelong plan that pairs them […]
Suicidal Thoughts Prompt New Warnings From Health Authorities For GLP-1 Drugs
Talk to your doctor.
Senior Product Manager
A company is looking for a Senior Product Manager to enhance member and care team experiences in healthcare. Key Responsibilities Create and execute a roadmap for the GLP-1 prescribing program to achieve performance targets Collaborate with care team and member operations to align business metrics Foster an innovative environment by encouraging cross-functional team collaboration Required […]
How Ozempic and Wegovy became globally recognized brands to treat obesity | DW News
For years, the standard medical advice to treat obesity was to eat less and to exercise more. But new drugs like Ozempic and Wegovy have become globally recognized brands, because they offer an alternative – and for many, an easier – way to lose weight. Now, the World Health Organization is endorsing those drugs – […]
GLP-1 Drugs for Cats? High-Dose Wegovy Heads to FDA; Smartphone-Obesity Link in Kids
(MedPage Today) — Weight-loss injectables for pets? Okava Pharmaceuticals announced plans to kick off a pilot study of a GLP-1 drug for cats with obesity. (New York Times) Novo Nordisk submitted a higher-dose version of semaglutide (Wegovy) to…
诺和诺德解释GLP-1阿尔茨海默病试验失败的缘由
Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer”s trials (www.reuters.com) 04:42
GLP-1 drugs may reach fewer than one in 10 people who need them, experts predict
The World Health Organization (WHO) has announced its official guidance on the use of GLP-1 drugs for treating obesity. GLP-1 drugs are medications that mimic the natural hormone glucagon-like peptide-1 (GLP-1), which are most commonly used for type 2 diabetes and medical weight loss. The first guideline, released on Dec. 1, aims to address the […]
Novo Nordisk justifies reasoning behind failed GLP-1 Alzheimer’s trials
Despite a lack of results from the trials, the Vice President of the company says “we still think it was the right decision.”
Nigerian General Christopher Musa returns to government as the country’s Minister of Defence
In tonight’s edition, a month after losing his jon a chief of defence staff amidst coup concerns, nigerian General Christopher Musa returns to government as the country’s Minister of Defence. Also, a well known south African radio presenter has been accused of recruiting young men to join the Russian army. And globally obersity numbers are creeping […]